Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, October 13, 2023
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
[ Fri, Oct 13th 2023
] - WOPRAI
Thu, October 12, 2023
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
[ Thu, Oct 12th 2023
] - WOPRAI
Joseph Pantginis Maintained (ATXS) at Strong Buy with Decreased Target to $18 on, Oct 12th, 2023
Joseph Pantginis of HC Wainwright & Co., Maintained "Astria Therapeutics, Inc." (ATXS) at Strong Buy with Decreased Target from $20 to $18 on, Oct 12th, 2023.
Joseph has made no other calls on ATXS in the last 4 months.
There is 1 other peer that has a rating on ATXS. Out of the 1 peers that are also analyzing ATXS, 0 agree with Joseph's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joseph
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $25 on, Tuesday, August 8th, 2023
